← Back to all grants

NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)

Funding
Amount varies
Deadline
April 28, 2027
Who can apply
State governments, County governments, City or township governments +11 more
Status: Open
Source: Grants.gov
View Official Grant Page ↗
Add the deadline to your calendar:Download .icsGoogle Calendar

Description

The purpose of the NHLBI Emerging Investigator Award (EIA) is to promote scientific productivity and innovation by providing long-term support and increased flexibility to experienced Program Directors/Principal Investigators (PDs/PIs) who are currently PDs/PIs on at least two NHLBI R01-equivalent awards and whose outstanding record of research demonstrates their ability to make major contributions to heart, lung, blood and sleep (HLBS) research. The EIA is intended to support a research program, rather than a research project, by providing the primary and most likely sole source of NHLBI funding on individual grant awards. The EIA will support the research program of NHLBI-funded investigators for up to seven years. The EIA will provide investigators increased freedom to conduct research that breaks new ground or extends previous discoveries in new directions. It will also allow PDs/PIs to take greater risks and to pursue research that requires a longer timeframe. Research supported by the EIA must be within the scope of the NHLBI mission (http://www.nhlbi.nih.gov/about/org/mission).

Who can apply

  • State governments
  • County governments
  • City or township governments
  • Special district governments
  • Independent school districts
  • Public and state-controlled colleges and universities
  • Federally recognized Native American tribal governments
  • Public and Indian housing authorities
  • Other Native American tribal organizations
  • Nonprofits with 501(c)(3) status
  • Nonprofits without 501(c)(3) status
  • Private colleges and universities
  • For-profit organizations (other than small businesses)
  • Small businesses

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Industry Tags

Healthcare

About This Grant

The purpose of the NHLBI Emerging Investigator Award (EIA) is to promote scientific productivity and innovation by providing long-term support and increased flexibility to experienced Program Directors/Principal Investigators (PDs/PIs) who are currently PDs/PIs on at least two NHLBI R01-equivalent awards and whose outstanding record of research demonstrates their ability to make major contributions to heart, lung, blood and sleep (HLBS) research. The EIA is intended to support a research program, rather than a research project, by providing the primary and most likely sole source of NHLBI funding on individual grant awards. The EIA will support the research program of NHLBI-funded investigators for up to seven years. The EIA will provide investigators increased freedom to conduct research that breaks new ground or extends previous discoveries in new directions. It will also allow PDs/PIs to take greater risks and to pursue research that requires a longer timeframe. Research supported by the EIA must be within the scope of the NHLBI mission (http://www.nhlbi.nih.gov/about/org/mission).

Funding Information

Funding amount not specified. See the official listing for details.

Eligibility Overview

Eligible applicants include: State governments, County governments, City or township governments +11 more. Always confirm on the official listing.

Eligibility requirements vary by opportunity. Always review the official listing before investing time in an application.

How to Apply

  1. 1

    Review the full opportunity

    Read the complete Notice of Funding Opportunity (NOFO) for this National Institutes of Health program on its official page (https://www.grants.gov/search-results-detail/353822).

  2. 2

    Confirm eligibility

    Check that your organization meets every requirement set by National Institutes of Health — applicant type, location, registration status, and any prior-award restrictions.

  3. 3

    Prepare required documents

    Gather your budget narrative, needs statement, organizational details, SAM.gov registration, and any required certifications.

  4. 4

    Submit before the deadline

    This opportunity closes on April 28, 2027. Submit well before the deadline to leave time for fixes.

Grant Writing Tips

General tips for preparing your application:

  • ✓Start early: registration and review steps take time.
  • ✓Match your needs statement to the funder's stated priorities.
  • ✓Have someone outside your team check the budget narrative.

More Grants from National Institutes of Health

Frequently Asked Questions

Who is eligible for NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)?

Eligible applicants include: State governments, County governments, City or township governments +11 more. Always confirm on the official listing.

How much funding does NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional) provide?

An award amount is not stated in the listing for NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional). See the official grant page for funding details.

When is the deadline for NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)?

The application deadline for NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional) is April 28, 2027. Submit well before the deadline to leave time for fixes.

How do I apply for NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)?

Apply for NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional) through the official grant page (https://www.grants.gov/search-results-detail/353822). Confirm your eligibility and prepare your application materials before the deadline.

Helpful Resources

✍️Grant Writing Help

Need help writing your grant application?

Try Instrumentl — Grant Writing Software →
🏢Start Your Business

Need to form an LLC or corporation first?

Form your business with ZenBusiness →
🤝Nonprofit Formation

Starting a nonprofit to apply for grants?

Launch your nonprofit with Swyft Filings →
📊Grant Management

Track and manage multiple grant applications?

Try Bloomerang for nonprofits →

GrantLocate may earn a commission from qualifying purchases. This does not affect our grant listings.

Related Grants